Skip to content
Review Open access

Beyond Traditional Risk Scores: Precision Medicine for Comprehensive Cardiovascular Risk Assessment in Women and Men

Oct 2026 · Journal of Clinical Medicine · Vol 15, pp. 8365 · 0 citations

Abstract

Background and Objectives: Conventional 10-year cardiovascular risk estimation algorithms are insufficient because they fail to integrate non-traditional clinical, biological, reproductive, and psychosocial modifiers that exhibit marked sex differences. The objective of this position framework is to address this gap by developing structured, sex-stratified clinical checklists for routine clinical practice. Methods: An expert narrative review and literature screening were conducted across PubMed/MEDLINE, Embase, Cochrane, and 14 international clinical practice guidelines (2020–2026 window) to identify robust sex-stratified risk modifiers. The multidisciplinary working group (comprising cardiology, gynecology, and primary care) conducted iterative internal review rounds to synthesize evidence and structure two comprehensive clinical checklists across six operational domains. Results: Epidemiological evidence mandates a life-course prevention model starting prior to conception. In women, obstetric history (preeclampsia, gestational diabetes, preterm birth), gynecological milestones (PMOS, endometriosis), early menopause, and oncological therapies markedly elevate vascular risk. In men, persistent erectile dysfunction, functional hypogonadism, androgen deprivation therapy, and premature androgenetic alopecia serve as early indicators of vascular and metabolic risk. Advanced biomarkers (Lp(a) ≥ 50 mg/dL, ApoB > 100 mg/dL, persistent hs-CRP ≥ 2 mg/L) and social determinants of health further refine risk stratification. Conclusions: Incorporating these structured checklists into daily consultations complements validated population risk scores (SCORE2, PREVENT, QRISK3), mitigates systematic underdiagnosis—especially in women—and provides an actionable framework for personalized cardiovascular prevention.

Read PDF

Similar papers

Review Open access Sep 2026

Coronary heart disease in young women: risk factors, mechanistic phenotypes, and implications for primary care

Coronary heart disease (CHD) in young women remains under-recognized because early risk signals are often dispersed across different clinical settings and symptoms are frequently interpreted as non-cardiac at first contact. This narrative review provides a clinically oriented synthesis that integrates conventional and...

Xiao-Xuan Li, Xiao-Ran Cui · 0 citations
Review Open access Oct 2026

Assessing clinical utility of genomic risk stratification for cancer prevention: a systematic review

Abstract Background Despite advances in genomics for cancer prevention, its clinical utility remains inadequately assessed. This study, conducted within the European Joint Action JANE2, synthesizes evidence on the clinical utility of genomic-based personalized preventive strategies. Methods We conducted a systematic re...

A. Sabatelli, S. Farina, E. Giacobini et al. · 0 citations
Review Open access Oct 2026

Underdetected peripheral artery disease in people with hypertension: A narrative review of risk-stratified case-finding, diagnostic pathways, and equity in care.

BACKGROUND Peripheral artery disease (PAD) is common but often underrecognized in people with hypertension because symptoms are frequently absent or atypical and access to physiologic testing is uneven. This narrative review examines how hypertension care can support risk-stratified PAD recognition while keeping target...

Guang-Zhe Li, Jia-Chang Yang, Kai-Lei Zhang et al. · 0 citations
Open access Sep 2026

Beyond the Pooled Cohort Equations: Challenges of ASCVD Risk Estimation in Qatar's Primary Care Population

Background: Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality in Qatar [1,2]. The Atherosclerotic Cardiovascular Disease (ASCVD) risk estimator, which implements the Pooled Cohort Equations (PCE), is widely used to guide preventive interventions but has not been formally validated for the...

Husameldin Elhimadie, Dinas Idris · 0 citations
Review Open access Sep 2026

Type 2 Diabetes and Central Obesity in the Cardiovascular Kidney–Metabolic Continuum: A Critical Narrative Review

Type 2 diabetes and central obesity frequently coexist, but coexistence does not establish a distinct disease entity, biological interaction, or treatment indication. This critical narrative review examines whether confirmed type 2 diabetes plus a standardised waist measurement can serve as a low-cost risk-recognition...

Dini Aulia Cahya, S. A. Dzulkarnain, B. J. Wrahatnala et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.